抗感染药物输液疗法

抗感染药物

输液治疗+

Option Care provides comprehensive home and alternate site infusion services to combat serious infections in patients of all ages. Our anti-infective infusion therapy services help patients avoid hospitalizations for many infections that can be safely treated at home.

防治严重感染的公认合作伙伴

我们广泛的服务覆盖范围确保全美各地几乎所有接受急性和慢性护理的患者都能迅速得到他们所需的产品供应和医疗保险支持。1

我们快速协调抗感染家庭输液护理,以避免昂贵的住院治疗

省时的入诊协调2
Option Care specialists confirm insurance benefits and respond to referral requests within 2 hours.* We start anti-infective infusion therapy for 9 out of 10 patients who are referred to us, and we can start a targeted treatment at a patient’s home within 24 hours, which helps avoid hospitalizations. This high start rate is achieved by facilitating insurance verification, connecting patients to appropriate financial assistance resources, and reviewing coverage and care with patients.

个性化护理计划
Many infections can be safely treated at home, and we customize anti-infective infusion therapy treatment plans to the specific needs of each AI patient. Our pharmacists conduct a full case review and consult with prescribing physicians and healthcare providers as needed to ensure appropriate antibiotic choices or suggest treatment adjustments. We adapt the established protocols to meet your requirements while helping to achieve optimal treatment outcomes.

临床监测和报告
抗感染药物 (AI) 专科护士在整个家庭和备选治疗站点输液疗法过程中监测和跟踪患者的状况。Option Care 将患者状况的不良变化通报给医师,并在医师或医疗保健提供者指定的时间间隔内提供常规更新。Option Care 可提供本地数据来帮助处方医师评估和提高护理质量,并避免卫生系统处罚。

长期支持和教育
Option Care 输液护士向患者和照料者提供关于抗感染药物家庭输液、自我护理和监测工具,以及适当的卫生护卫等方面的建议。在感染方面,我们一直致力于优化疗效,使患者能够尽早地从静脉注射抗生素转为口服药物。Option Care 安排了经验丰富的临床医师提供全天候的患者支持。

*收到所有必要文件的平均时间。

每年有多达 400 万人可以避免住院。”

—美国医疗保健研究与质量管理署3

再入院的患者人数远低于全美平均水平

不到 1% 的 Option Care 抗感染药物输液患者再入院 — 与全美平均水平相比人数大幅减少。4我们的跨学科方法帮助我们实现了这一卓越的成果。药剂师监测患者的护理情况,并在必要时进行干预。据估计,每次药剂师干预可避免平均 1,623 美元的费用。5

Option Care 治疗最常见的感染诊断

Treat the Most Common Infections with Option Care Anti-Infective Infusion Therapy

†干预措施包括预防和管理药物之间相互作用和药物不良反应,以及改变疗法,包括调整剂量、频率、途径或治疗持续时间。‡基于美国医疗保健研究与质量管理署制定的标准所得出的全国平均数。数据于 2010 年 1 月至 11 月利用最大的支付方医疗保健数据库“医疗成本与效用项目” (HCUP) 采集而成,其中包括住院患者、门诊手术和急诊科治疗。这些门诊患者的家庭、诊所和门诊输液套件数据是基于一名 Option Care 员工于 2012 年 9 月至 2013 年 8 月输入的事件报告,无论支付方是谁。

参考文献:
1. Option Care coverage area data. STI: PopStats, Austin, TX. Calculated 04/28/14. 2. Data on file, Option Care. 3. Agency for Healthcare Research and Quality. Four million hospital admissions potentially unnecessary. AHRQ News and Numbers. November 3, 2010. Rockville, MD. Accessed January 5, 2015. 4. Review of Option Care patient data, October 2009-February 2011. Based on an average 39,978 patients per month. 5. Retrospective review (August 2012-­January 2013) of patients who received home infusions of parenteral vancomycin and aminoglycosides. Of 9,223 total patients, 257 were randomly selected and reviewed for pharmacist interventions performed. 6. Review of Option Care patient data, September 2012-­August 2013. Based on review of 45,917 anti-­infective patients. 7. Elixhauser A, Steiner C. Readmissions to U.S. hospitals by diagnosis, 2010. Healthcare Cost and Utilization Project, Agency for Healthcare Research